Posting of Annual Report & Accounts and Notice of AGM
Posting of Annual Report & Accounts and Notice of AGM
September 6, 2019
Download full announcement
Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical in vitro diagnostics for kidney disease, confirms that the Annual Report and Accounts for the period ended 30 June 2019 (“2019 Annual Report”), the Notice of the Annual General Meeting contained therein (the “Notice of AGM”) and forms of proxy are being posted to shareholders today and are available now on the Company’s website in accordance with AIM Rule 20:
The AGM is to be held on 30 September 2019 at 11am at the offices of Harwood Capital LLP, 6 Stratton Street, Mayfair, London W1J 8LD.
Enquiries
| Renalytix AI plc | www.renalytixai.com |
| James McCullough, CEO | Via Walbrook PR or Tel: +1 646 397 3970 |
| Stifel (Nominated Adviser & Joint Broker) | Tel: 020 7710 7600 |
|
Alex Price / Jonathan Senior / Ben Maddison (Investment Banking) |
|
| N+1 Singer (Nominated Adviser & Broker) | Tel: 020 7496 3000 |
| Aubrey Powell / James White / George Tzimas (Corporate Finance) Tom Salvesen / Mia Gardner (Corporate Broking) |
|
| Walbrook PR Limited | Tel: 020 7933 8780 renalytix@walbrookpr.com |
| Paul McManus Lianne Cawthorne |
Mob: 07980 541 893 07584 391 303 |